Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice

Respiratory Research

Volumn 8, Issue , 2007, Pages

  Blasi, Francesco ^a   Aliberti, Stefano ^a   Allegra, Luigi ^a   Piatti, Gioia ^a   Tarsia, Paolo ^a   Ossewaarde, Jacobus M ^b   Verweij, Vivienne ^c   Nijkamp, Frans P ^c   Folkerts, Gert ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; CXCL2 PROTEIN, MOUSE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; CHEMISTRY; CHLAMYDOPHILA PNEUMONIAE; CYTOLOGY; DISEASE MODEL; EUKARYOTIC FLAGELLUM; HYPERTROPHY; LUNG; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SCANNING ELECTRON MICROSCOPY; TIME; ULTRASTRUCTURE;

ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CXCL2; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CILIA; DISEASE MODELS, ANIMAL; HYPERTROPHY; INTERFERON TYPE II; LUNG; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; PNEUMONIA, BACTERIAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUCOSA; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38349139552     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-8-83     Document Type: Article

References (45)

1. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Bmj 1995, 310(6989):1225-1229.
2. Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998, 157(6 Pt 1):1708-1720.
3. Folkerts G, Walzl G, Openshaw PJ. Do common childhood infections 'teach' the immune system not to be allergic?. Immunol Today 2000, 21(3):118-120. 10.1016/S0167-5699(00)01582-6, 10777250.
4. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. Jama 1991, 266(2):225-230. 10.1001/jama.266.2.225, 2056624.
5. Emre U, Roblin PM, Gelling M, Dumornay W, Rao M, Hammerschlag MR, Schachter J. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994, 148(7):727-732.
6. File TM, Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. Infect Dis Clin North Am 1998, 12(3):569-92, vii. 10.1016/S0891-5520(05)70199-9, 9779379.
7. Cunningham AF, Johnston SL, Julious SA, Lampe FC, Ward ME. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 1998, 11(2):345-349. 10.1183/09031936.98.11020345, 9551736.
8. Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, Gaydos CA, Martin RJ. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998, 158(3):998-1001.
9. Nagy A, Kozma GT, Keszei M, Treszl A, Falus A, Szalai C. The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin. J Allergy Clin Immunol 2003, 112(4):729-734. 10.1016/S0091-6749(03)02010-4, 14564351.
10. Sirmatel F, Ustunsoy H, Sirmatel O, Akdemir I, Dikensoy O. The relationship between Chlamydia pneumoniae seropositivity and peripheral vascular diseases, acute myocardial infarction and late-onset asthma. Infection 2003, 31(5):367-368.
11. Clementsen P, Permin H, Norn S. Chlamydia pneumoniae infection and its role in asthma and chronic obstructive pulmonary disease. J Investig Allergol Clin Immunol 2002, 12(2):73-79.
12. Blasi F, Damato S, Cosentini R, Tarsia P, Raccanelli R, Centanni S, Allegra L. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 2002, 57(8):672-676. 10.1136/thorax.57.8.672, 12149525.
13. Hammerschlag MR. The intracellular life of chlamydiae. Semin Pediatr Infect Dis 2002, 13(4):239-248. 10.1053/spid.2002.127201, 12491229.
14. Leinonen M. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 1993, 14 Suppl K:57-61.
15. Pal S, Peterson EM, de La Maza LM. Role of Nramp1 deletion in Chlamydia infection in mice. Infect Immun 2000, 68(8):4831-4833. 98449, 10899900, 10.1128/IAI.68.8.4831-4833.2000.
16. Komura H, Matsushima H, Ouchi K, Shirai M, Nakazawa T, Furukawa S. Effects of antiasthma drugs on the growth of Chlamydophila pneumoniae in HEp-2 cells. J Infect Chemother 2003, 9(2):160-164.
17. Burian K, Hegyesi H, Buzas E, Endresz V, Kis Z, Falus A, Gonczol E. Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung. Immunol Lett 2003, 89(2-3):229-236. 10.1016/S0165-2478(03)00154-8, 14556983.
18. Yang ZP, Cummings PK, Patton DL, Kuo CC. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J Infect Dis 1994, 170(2):464-467.
19. Kaukoranta-Tolvanen SS, Laurila AL, Saikku P, Leinonen M, Liesirova L, Laitinen K. Experimental infection of Chlamydia pneumoniae in mice. Microb Pathog 1993, 15(4):293-302. 10.1006/mpat.1993.1079, 8309355.
20. Blasi F, Boman J, Esposito G, Melissano G, Chiesa R, Cosentini R, Tarsia P, Tshomba Y, Betti M, Alessi M, Morelli N, Allegra L. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis 1999, 180(6):2074-2076. 10.1086/315126, 10558974.
21. Meijer A, Roholl PJ, Gielis-Proper SK, Meulenberg YF, Ossewaarde JM. Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods. J Clin Pathol 2000, 53(12):904-910. 1731138, 11265174, 10.1136/jcp.53.12.904.
22. Tamaoki J, Araake M, Chiyotani A, Isono K, Nagai A. Airway hyperresponsiveness to histamine in mycoplasmal infection: role of histamine N-methyltransferase. Eur J Pharmacol 1998, 347(2-3):257-260. 10.1016/S0014-2999(98)00177-0, 9653891.
23. Chu HW, Honour JM, Rawlinson CA, Harbeck RJ, Martin RJ. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 2003, 71(3):1520-1526. 148884, 12595471, 10.1128/IAI.71.3.1520-1526.2003.
24. Dechend R, Maass M, Gieffers J, Dietz R, Scheidereit C, Leutz A, Gulba DC. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 1999, 100(13):1369-1373.
25. Bureau F, Bonizzi G, Kirschvink N, Delhalle S, Desmecht D, Merville MP, Bours V, Lekeux P. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1314-1321.
26. Johnston SL, Blasi F, Black PN, Martin RJ, Farrell DJ, Nieman RB. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006, 354(15):1589-1600. 10.1056/NEJMoa044080, 16611950.
27. Folkerts G, Vlieger JW, de Vries A, Faas S, van Der Linde H, Engels F, de Jong JC, Verheyen FA, Van Heuven-Nolsen D, Nijkamp FP. Virus- and bradykinin-induced airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 2000, 161(5):1666-1671.
28. Smit JJ, Van Loveren H, Hoekstra MO, Karimi K, Folkerts G, Nijkamp FP. The Slc11a1 (Nramp1) gene controls efficacy of mycobacterial treatment of allergic asthma. J Immunol 2003, 171(2):754-760.
29. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, Folkerts G, Nijkamp FP, Blalock JE. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 2006, 12(3):317-323. 10.1038/nm1361, 16474398.
30. Hofstra CL, Van Ark I, Hofman G, Nijkamp FP, Jardieu PM, Van Oosterhout AJ. Differential effects of endogenous and exogenous interferon-gamma on immunoglobulin E, cellular infiltration, and airway responsiveness in a murine model of allergic asthma. Am J Respir Cell Mol Biol 1998, 19(5):826-835.
31. Folkerts G, Verheyen AK, Geuens GM, Folkerts HF, Nijkamp FP. Virus-induced changes in airway responsiveness, morphology, and histamine levels in guinea pigs. Am Rev Respir Dis 1993, 147(6 Pt 1):1569-1577.
32. Esposito S, Blasi F, Arosio C, Fioravanti L, Fagetti L, Droghetti R, Tarsia P, Allegra L, Principi N. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000, 16(6):1142-1146. 10.1034/j.1399-3003.2000.16f21.x, 11292120.
33. Black PN, Blasi F, Jenkins CR, Scicchitano R, Mills GD, Rubinfeld AR, Ruffin RE, Mullins PR, Dangain J, Cooper BC, David DB, Allegra L. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001, 164(4):536-541.
34. Betsou F, Sueur JM, Orfila J. Anti-Chlamydia pneumoniae heat shock protein 10 antibodies in asthmatic adults. FEMS Immunol Med Microbiol 2003, 35(2):107-111. 10.1016/S0928-8244(03)00003-8, 12628545.
35. Seemungal TA, Wedzicha JA, MacCallum PK, Johnston SL, Lambert PA. Chlamydia pneumoniae and COPD exacerbation. Thorax 2002, 57(12):1087-8; author reply 1088-9. 10.1136/thorax.57.12.1087-a, 12454307.
36. Wu L, Skinner SJ, Lambie N, Vuletic JC, Blasi F, Black PN. Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162(3 Pt 1):1148-1151.
37. Lieberman D, Ben-Yaakov M, Lazarovich Z, Ohana B, Boldur I. Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations. Eur J Clin Microbiol Infect Dis 2001, 20(10):698-704. 10.1007/s100960100596, 11757970.
38. Rodel J, Woytas M, Groh A, Schmidt KH, Hartmann M, Lehmann M, Straube E. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect Immun 2000, 68(6):3635-3641. 97653, 10816522, 10.1128/IAI.68.6.3635-3641.2000.
39. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 1996, 21(3):215-221. 10.1006/mpat.1996.0056, 8878018.
40. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998, 98(4):300-307.
41. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 1995, 25 Suppl 2:S9-12.
42. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, FitzGerald MX, O'Connor CM. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997, 156(1):240-247.
43. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004, 84(3):731-765. 10.1152/physrev.00034.2003, 15269335.
44. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998, 157(1):4-9.
45. Karnak D, Beder S. Treatment of Chlamydia pneumoniae infection and chronic obstructive pulmonary disease. Expert Opin Pharmacother 2002, 3(10):1461-1470. 10.1517/14656566.3.10.1461, 12387692.